JPS63196277A - Substrate for cell culture - Google Patents
Substrate for cell cultureInfo
- Publication number
- JPS63196277A JPS63196277A JP2900787A JP2900787A JPS63196277A JP S63196277 A JPS63196277 A JP S63196277A JP 2900787 A JP2900787 A JP 2900787A JP 2900787 A JP2900787 A JP 2900787A JP S63196277 A JPS63196277 A JP S63196277A
- Authority
- JP
- Japan
- Prior art keywords
- cell culture
- cells
- substrate
- lipids
- base material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000758 substrate Substances 0.000 title claims description 43
- 238000004113 cell culture Methods 0.000 title claims description 36
- 239000000463 material Substances 0.000 claims description 24
- 239000012510 hollow fiber Substances 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 11
- 150000002632 lipids Chemical class 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 7
- -1 ozone sugars Chemical class 0.000 claims description 7
- 150000008163 sugars Chemical class 0.000 claims description 7
- 235000015097 nutrients Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 53
- 108090000288 Glycoproteins Proteins 0.000 description 23
- 102000003886 Glycoproteins Human genes 0.000 description 23
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 229920000307 polymer substrate Polymers 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 7
- 210000004102 animal cell Anatomy 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 208000030275 Chondronectin Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920004738 ULTEM® Polymers 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 108010031318 Vitronectin Proteins 0.000 description 1
- 102100035140 Vitronectin Human genes 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 150000002298 globosides Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108700020610 human chondronectin Proteins 0.000 description 1
- 102000043667 human chondronectin Human genes 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006380 polyphenylene oxide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
〈産業上の利用分野〉
この発明は、細胞培養用基材に関する。さらに詳細には
、動物細胞を培養するために使用される細胞培養用基材
に関するものである。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a substrate for cell culture. More specifically, the present invention relates to a cell culture substrate used for culturing animal cells.
〈従来の技術〉
近年、生物の細胞を培養し、その細胞の代謝活動により
有用な生理活性物質、例えば、ワクチン、ホルモン、イ
ンターフェロン等を生産する研究が活発に行われている
。<Prior Art> In recent years, research has been actively conducted to cultivate biological cells and produce useful physiologically active substances, such as vaccines, hormones, and interferons, through the metabolic activities of the cells.
このような方法において、従来、接着性動物細胞の培養
は、ガラス、プラスチック製のシャーレ、試験管、培養
ビンなどを用いて行なわれてきた。In such methods, adherent animal cells have conventionally been cultured using glass or plastic petri dishes, test tubes, culture bottles, and the like.
また、最近、マイクロキャリアや中空糸を培養用基材と
して用い、より゛高密度の培養や、長期の培養を行なう
試みがなされつつある。接着性動物細胞を培養周基村上
に接着させ、増殖させるには、該基材表面と細胞の接着
性が良好であることと共に接着した細胞の形態、配列が
、細胞の伸展、増殖に有効な形態になっていることが必
要である。Recently, attempts have been made to use microcarriers and hollow fibers as culture substrates to achieve higher-density culture and longer-term culture. In order to adhere and proliferate adherent animal cells on a cultured substrate, it is necessary to ensure that the adhesion between the substrate surface and the cells is good, and that the morphology and arrangement of the adhered cells are effective for cell expansion and proliferation. It is necessary to be in the form.
しかしながら、従来から細胞培養用基材として用いられ
ている高分子材料は賦形性、耐久性に優れるものの、上
記接着性等の点に関して不適当であり、高密度かつ長期
間の細胞培養を行なうことができず、いずれも十分な成
果を上げるに至っていない。However, although the polymer materials conventionally used as substrates for cell culture have excellent shapeability and durability, they are unsuitable in terms of adhesive properties, etc., and cannot be used for high-density and long-term cell culture. However, none of them have been able to achieve sufficient results.
一方、糖、蛋白質、脂質およびこれらの複合化合物は、
細胞の接着に関与することが知られている。高分子材料
上にこれらの物質をコーティングして培養用基材とする
試みがあり、既にコラーゲンやその変性物であるゼラチ
ンを塗布した培養用シャーレが市販されている他、可溶
性フィブロインの架橋体が積層された細胞培養床(特開
昭61−52280号公報参照)が提案されている。On the other hand, sugars, proteins, lipids, and their complex compounds are
It is known to be involved in cell adhesion. Attempts have been made to coat polymeric materials with these substances as culture substrates, and culture dishes coated with collagen or gelatin, a modified product of collagen, are already commercially available, as well as cross-linked soluble fibroin. A stacked cell culture bed (see JP-A-61-52280) has been proposed.
〈発明が解決しようとする問題点〉
しかしながら、上記の従来技術は 高分子基材への糖蛋
白質等の固定が十分でなく容易に脱離してしまうという
問題がある。さらに、これらの方法による細胞培養用基
材は、いずれも材料表面の全面が処理された基材しか得
らず、接着した細胞の配列、形態を細胞の伸展、増殖に
有利な形態に制御することができないという問題がある
。従って、上記の細胞培養用基材は、細胞との接着性お
よび細胞の伸展性と増殖性が不十分であり、細胞培養を
高密度かつ長期に亘って行なうことができないという問
題点がある。<Problems to be Solved by the Invention> However, the above-mentioned conventional technology has a problem in that glycoproteins and the like are not sufficiently immobilized on the polymeric substrate and are easily detached. Furthermore, all of the cell culture substrates produced by these methods can only be obtained with the entire surface of the material treated, and the arrangement and morphology of adhered cells can be controlled to be favorable for cell expansion and proliferation. The problem is that I can't. Therefore, the above-mentioned cell culture substrate has insufficient adhesion with cells, cell spreadability and proliferation, and there is a problem in that cell culture cannot be carried out at high density and over a long period of time.
く目 的〉
この発明は上記問題点に鑑みてなされたものであり、細
胞との接着性に優れ、細胞の増殖と機能維持を行う・こ
とのでき、高密度、長期間の細胞培養を可能ならしめる
細胞培養用基材を提供することを目的とする。Purpose This invention was made in view of the above-mentioned problems, and it has excellent adhesion with cells, can proliferate cells and maintain their functions, and enables high-density, long-term cell culture. The purpose is to provide a cell culture substrate that can be conditioned.
く問題点を解決するための手段および作用〉上記の問題
点を解決すべくなされた、この発明の細胞培養用基材は
、オゾンにより表面処理された高分子基材の表面上に、
糖、蛋白質、脂質およびそれらの複合化合物(以下、こ
れらを糖蛋白質等と称する)のいずれか1種類以上が担
持されていることを特徴とするものである。Means and action for solving the above problems> The cell culture substrate of the present invention, which was made to solve the above problems, has a polymer substrate surface-treated with ozone, and on the surface of the polymer substrate,
It is characterized in that it supports one or more of sugars, proteins, lipids, and complex compounds thereof (hereinafter referred to as glycoproteins, etc.).
なお、上記高分子基材は、多孔質材料であるのが好まし
い。また、上記基材が中空糸であるものが好ましい。さ
らには、基材上に糖蛋白質等が部分的に担持されている
のが好ましく、特に、格子模様、縞模様、水玉模様等に
担持されているものが好ましい。Note that the polymer base material is preferably a porous material. Further, it is preferable that the base material is a hollow fiber. Furthermore, it is preferable that the glycoprotein or the like is partially supported on the base material, particularly preferably in a checkered pattern, striped pattern, polka dot pattern, etc.
この発明の細胞培養用基材は、上記の構成よりなり、オ
ゾンにより酸化された高分子基材表面に糖蛋白質等が担
持されているので、該基材と糖蛋白質等との接着を強固
にすることができる。さらに、糖蛋白質等は、細胞との
接着性に優れ、細胞が安定した形態、配置で接着するこ
とができる。The cell culture substrate of the present invention has the above-mentioned structure, and since glycoproteins, etc. are supported on the surface of the polymer substrate oxidized by ozone, the adhesion between the substrate and glycoproteins, etc. is strong. can do. Furthermore, glycoproteins and the like have excellent adhesion to cells, allowing cells to adhere in a stable form and arrangement.
すなわち、細胞表面の細胞膜の構造は、脂質二重層の中
に、膜内粒子と呼ばれる各種の糖蛋白質、糖脂質等が分
布をもって埋めこまれており、これらが、上記脂質二重
層の中を自由に移動でき細胞の接着に関与している。上
記糖蛋白質等は、膜内粒子とイオン結合、疎水結合等に
より結合可能な部位を有するので、細胞との接着性が高
まると共に細胞を安定した形態、配置で保持することが
できる。従って、本発明の細胞培養用基材は、細胞の安
定な接着を促すと共に接着した細胞の良好な伸展および
増殖を可能にすることができる。In other words, the structure of the cell membrane on the cell surface is such that various glycoproteins, glycolipids, etc., called intramembrane particles, are embedded in a lipid bilayer in a distributed manner, and these particles freely move inside the lipid bilayer. It is involved in cell adhesion. Since the above-mentioned glycoproteins and the like have sites that can bind to intramembrane particles through ionic bonds, hydrophobic bonds, etc., they can increase adhesion to cells and maintain cells in a stable shape and arrangement. Therefore, the cell culture substrate of the present invention can promote stable adhesion of cells and enable good spread and proliferation of adhered cells.
また、上記高分子基材が、多孔質材料であるときは、多
孔質材料の孔を通じて物質代謝が容易となり長期に亘り
細胞培養することができる。特に、前記高分子基材が中
空糸であるものは、中空部内や中空糸の外側に培養液等
を潅流することにより、中空糸上に細胞を高密度に育成
、増殖させることができる。Furthermore, when the polymer base material is a porous material, substance metabolism is facilitated through the pores of the porous material, and cells can be cultured for a long period of time. In particular, when the polymer base material is a hollow fiber, cells can be grown and multiplied at high density on the hollow fiber by perfusing a culture solution or the like into the hollow portion or outside of the hollow fiber.
また、基材の表面に糖蛋白質等が部分的に担持されてい
るもの、特に、格子模様、縞模様、水玉模様等に糖蛋白
質等が担持されているものは、接着する細胞の位置を調
整でき、細胞が所定の間隔をもって接着するので、細胞
との接着がさらに安定化し、細胞の伸展、増殖をより一
層増大させることができる。In addition, when glycoproteins, etc. are partially supported on the surface of the substrate, especially when glycoproteins, etc. are supported in a checkered pattern, striped pattern, polka dot pattern, etc., the position of the adhering cells can be adjusted. Since the cells adhere at predetermined intervals, the adhesion with the cells is further stabilized, and the spread and proliferation of the cells can be further increased.
以下、この発明をより詳細に説明する。This invention will be explained in more detail below.
この発明の細胞培養用基材は、オゾンにより表面処理さ
れた高分子基材の表面上に、糖蛋白質等のいずれか1種
類以上が担持された構造を有する。The cell culture substrate of the present invention has a structure in which one or more types of glycoproteins or the like are supported on the surface of a polymer substrate that has been surface-treated with ozone.
上記高分子基材の材料としては、賦形性、機械的強度を
、有するものであればいかなるものでも使用でき、例え
ば、ポリエチレン、ポリプロピレン、塩素化ポリエチレ
ン、アイオノマー等のオレフィン系重合体、ポリテトラ
フルオロエチレン、ポリフッ化ビニリデン等のフッ素系
樹脂、ポリスチレン等のスチレン系樹脂、ポリメチルメ
タクリレート等のアクリル系樹脂、ポリビニ、ルアルコ
ール、ポリ酢酸ビニル、ポリビニルアセクール、ポリア
クリロニトリル、ポリ塩化ビニル、ポリ塩化ビニリデン
、ポリカーボネート、ボリアリレート、ポリフェニレン
オキサイド、ポリエチレンテレフタレート、ポリブチレ
ンテレフタレート等のポリエステル樹脂、エポキシ樹脂
、ポリアミド、ポリイミド、ポリスルホン、セルロース
系樹脂、シリコーン樹脂、ポリウレタンなどの種々の重
合体もしくは共重合体またはそれらのブレンド物が例示
できる。As the material for the polymer base material, any material can be used as long as it has shapeability and mechanical strength, such as polyethylene, polypropylene, chlorinated polyethylene, olefin polymers such as ionomers, polytetra Fluorine resins such as fluoroethylene and polyvinylidene fluoride, styrene resins such as polystyrene, acrylic resins such as polymethyl methacrylate, polyvinyl alcohol, polyvinyl acetate, polyvinyl acecool, polyacrylonitrile, polyvinyl chloride, polychloride Various polymers or copolymers such as vinylidene, polycarbonate, polyarylate, polyphenylene oxide, polyethylene terephthalate, polyester resin such as polybutylene terephthalate, epoxy resin, polyamide, polyimide, polysulfone, cellulose resin, silicone resin, polyurethane, or the like. An example is a blend of the following.
上記高分子材料からなる基材は、種々の形態に形成でき
、例えば、シャーレ、フラスコ等の成形品の他、フィル
ム、チューブ、中空糸、繊維、微粒子等の形態が例示で
きる。これらの形態のうち、長期に亘り細胞培養を行な
うには、物質代謝を容易にする孔を有する多孔質高分子
基材が好ましく、また、高密度培養を行なうには、チ、
ユーブ、中空糸の形状が好適である。特に、物質代謝が
容易で、高密度培養を長期に亘り行なえる多孔質高分子
基材からなる中空糸が好ましい。この中空糸を用いると
き、培養液を、中空糸の中空部または外側に潅流させ、
必要に応じて炭酸ガスや空気等を上記中空糸の中空部等
に送ることにより、細胞を中空糸上で育成し、増殖させ
ることができる。なお、前記中空糸としては、種々の大
きさのものが使用でき、例えば、内径50〜1000μ
−程度のものが用いられる。The base material made of the above-mentioned polymeric material can be formed into various shapes, including molded products such as petri dishes and flasks, as well as films, tubes, hollow fibers, fibers, and fine particles. Among these forms, for long-term cell culture, porous polymer substrates having pores that facilitate material metabolism are preferable, and for high-density culture,
A hollow fiber shape is preferred. Particularly preferred is a hollow fiber made of a porous polymer base material, which is easy to metabolize and can be cultured at high density for a long period of time. When using this hollow fiber, the culture solution is perfused into the hollow part or outside of the hollow fiber,
Cells can be grown and proliferated on the hollow fibers by sending carbon dioxide gas, air, etc. to the hollow portions of the hollow fibers as needed. Note that the hollow fibers can be of various sizes, for example, those with an inner diameter of 50 to 1000 μm.
- degree is used.
また、この発明の細胞培養用基材をマイクロキャリアー
法のビーズ担体として使用する場合には、前記高分子基
材は100〜30〇−程度の粒径のものが用いられる。Further, when the cell culture substrate of the present invention is used as a bead carrier in a microcarrier method, the polymer substrate used has a particle size of about 100 to 300 mm.
上記高分子基材の表面をオゾン処理する方法は、慣用の
方法が用いられ、例えば、高分子基材が配設された反応
容器内に、オゾン発生装置により発生させたオゾン(必
要に応じて、アルゴン等の不活性ガスとの混合ガスとし
て)を導入することにより行われる。所望に応じて、加
圧条件下に行なってもよく、また有機溶媒等を用いても
よい。反応容器中のオゾンの濃度は、通常0.2〜・1
0容量%、好ましくは0.3〜3容量%とされ、反応は
通常室温で行われる。オゾン処理した後、通常の方法に
従って、水洗、乾燥される。A conventional method is used to treat the surface of the polymer base material with ozone, for example, ozone generated by an ozone generator (if necessary) is placed in a reaction vessel in which the polymer base material is placed. , as a mixed gas with an inert gas such as argon). If desired, the reaction may be carried out under pressurized conditions, or an organic solvent or the like may be used. The concentration of ozone in the reaction container is usually 0.2 to 1.
The amount is 0% by volume, preferably 0.3-3% by volume, and the reaction is usually carried out at room temperature. After the ozone treatment, it is washed with water and dried according to the usual method.
上記のオゾン処理を行なった後、基材上に糖蛋白質等を
担持させる。ここで用いる糖蛋白質等は、細胞と親和性
、があり、基材と細胞の接着を促進するものであればい
ずれも用いることができ、例え、ば、ラクトース、ガラ
クトース等のオリゴ糖、アルブミン等の蛋白質、リン脂
質等の脂質、グロボシド、ガングリオシド等の糖と脂質
との複合体である糖脂質、細胞質や血清中に含まれる脂
質と蛋白質との複合体であるリボ蛋白質、糖と蛋白質と
の複合体である糖蛋白質等が挙げられ、特にオリゴ糖や
コラーゲン、ゼラチン、フィブロネクチン、ラミニン、
コンドロネクチン、ビトロネクチン、フィブリン等の糖
蛋白質が好適に用いられ、これらは2種またはそれ以上
組み合せて使用することも有用である。基材上に糖蛋白
質等を担持する方法は、従来の技術がいずれも応用でき
る。一般には、オゾンにより表面処理された高分子基材
を、上記の糖蛋白質等の1種類または2種類以上を含有
する溶液に浸漬したり、該溶液を基材上に塗布した後、
乾燥することにより行われる。この際、糖蛋白質等が変
性しにくい条件で乾燥するのが好ましい。After performing the above ozone treatment, glycoproteins and the like are supported on the base material. The glycoprotein used here can be any substance that has an affinity for cells and promotes adhesion between the substrate and cells, such as oligosaccharides such as lactose and galactose, albumin, etc. proteins, lipids such as phospholipids, glycolipids which are complexes of sugars and lipids such as globosides and gangliosides, riboproteins which are complexes of lipids and proteins contained in cytoplasm and serum, and complexes of sugars and proteins. Examples include complex glycoproteins, especially oligosaccharides, collagen, gelatin, fibronectin, laminin,
Glycoproteins such as chondronectin, vitronectin, and fibrin are preferably used, and it is also useful to use two or more of these in combination. Any conventional technique can be applied to the method of supporting glycoprotein etc. on the substrate. In general, a polymer substrate surface-treated with ozone is immersed in a solution containing one or more of the above-mentioned glycoproteins, etc., or after the solution is applied onto the substrate,
This is done by drying. At this time, it is preferable to dry under conditions that do not easily denature glycoproteins and the like.
上記糖蛋白質等の担持は、単分子層、多分子層のいずれ
でもよく、また基材表面の全面に積層してもよいが、基
材表面に部分的に、特にパターン化して担持したものが
好ましく、このようにパターン化して担持することによ
り、基材上に接告する細胞の配置を制御でき、ひいては
細胞の接着性が安定化し、細胞の伸展、増殖および機能
発現を有利にすることができる。さらに、糖蛋白質等を
上記のように部分的に担持する場合、特に、格子状、縞
模様、水玉模様等の微細模様に担持するこλにより、上
記効果をさらに増進できる有用な表面を形成することが
できる。基材上に糖蛋白質等をパターン化して担持する
には、例えば、スクリーン印刷等の技術を応用して行な
うことができる。The above-mentioned glycoproteins, etc. may be supported in either a monomolecular layer or a multimolecular layer, or may be laminated over the entire surface of the base material, but it is preferable to support them partially, especially in a pattern, on the surface of the base material. Preferably, by supporting the cells in a patterned manner, it is possible to control the arrangement of cells adhering to the substrate, which in turn stabilizes the adhesion of the cells, making it advantageous for cell spreading, proliferation, and functional expression. can. Furthermore, when glycoproteins, etc. are partially supported as described above, in particular, by supporting them in a fine pattern such as a lattice pattern, a striped pattern, a polka dot pattern, etc., a useful surface that can further enhance the above effects is formed. be able to. Glycoproteins and the like can be patterned and supported on the base material by, for example, applying techniques such as screen printing.
この発明の細胞培養用基材は、種々の細胞の培養に使用
することができ、細胞の種類は特に限定されず生体由来
細胞、ハイブリドーマ−等が挙げられ、例えば、チャイ
ニーズハムスター肺由来細胞V−79、ヒト子宮癌由来
細胞HeLa、ヒト胎児肺由来細胞MRC−5、ヒト肝
由来細胞Chang Liver s ヒト肺由来正二
倍体線維芽細胞lRe−90、ヒトリンパ腫由来ナマル
バ細胞等が例示される。The cell culture substrate of the present invention can be used for culturing various cells, and the type of cells is not particularly limited, and examples include living body-derived cells, hybridomas, etc. For example, Chinese hamster lung-derived cells V- 79, human uterine cancer-derived cells HeLa, human fetal lung-derived cells MRC-5, human liver-derived cells Chang Livers, human lung-derived eudiploid fibroblasts IRe-90, human lymphoma-derived Namalva cells, and the like.
また、この発明の細胞培養用基材を用いて動物細胞を培
養する場合、培養する細胞の種類に応じて種々の培養液
が用いられ、細胞の増殖に適した至適温度、pH等の条
件で培養が行なわれる。Furthermore, when culturing animal cells using the cell culture substrate of the present invention, various culture solutions are used depending on the type of cells to be cultured, and conditions such as optimal temperature and pH suitable for cell proliferation are used. Culture is carried out in
本発明の細胞培養用基材は、従来公知の種々のモジュー
ルにて、動物細胞の増殖に適用できる。The cell culture substrate of the present invention can be applied to the proliferation of animal cells in various conventionally known modules.
本発明の細胞培養基材としてフィルム状基材を用いたモ
ジュールの一例を、第1図に基づいて説明すると以下の
通りである。An example of a module using a film-like substrate as a cell culture substrate of the present invention will be described below based on FIG.
第1図に示す細胞培養器は、サポートスクリーン(2)
上に載置されたフィルム状基材(1)の両端が、ポリカ
ーボネート等からなるハウジング(3)内の両側に設け
られたスペーサ(6)により保持されている。The cell culture vessel shown in Figure 1 has a support screen (2).
Both ends of the film-like base material (1) placed thereon are held by spacers (6) provided on both sides within a housing (3) made of polycarbonate or the like.
また、上記ハウジング(3)には、増殖させる細胞懸濁
液をハウジング(3)内に満すための孔(4)が設けら
れていると共に、培養液を潅流させるための管6)が取
付られている。なお、上記孔(4)は、細菌等が侵入す
るのを防止するため、フィルタ付きの蓋(7)で被冠さ
れている。Further, the housing (3) is provided with a hole (4) for filling the housing (3) with a cell suspension to be proliferated, and a tube 6) for perfusing the culture solution is attached. It is being The hole (4) is covered with a lid (7) equipped with a filter to prevent bacteria from entering.
上記の細胞培養器を用いて細胞を増殖させるには、上記
孔(4)から細胞懸濁液を注入して細胞を前記基材(1
)上に接着させると共に、前記孔(4)をフィルタ付き
の上記蓋(7)で被冠し、所定の培養条件の下、上記培
養液を前記管(5)を通じて所定時間漕法させることに
より行なわれる。In order to proliferate cells using the cell culture device described above, a cell suspension is injected through the hole (4) and the cells are grown in the substrate (1).
), the hole (4) is covered with the lid (7) with a filter, and the culture solution is allowed to flow through the tube (5) for a predetermined period of time under predetermined culture conditions. It is done.
〈実施例〉
以下、実施例に基づいてこの発明をより詳細に説明する
。<Examples> Hereinafter, the present invention will be described in more detail based on Examples.
実施例1および比較例
ポリスルホン(UCC社製、U d e l P17
00)からなる厚さ50μ−、径45m+nφのフィル
ムをガス導入口と排出口を備えたデシ“ケータ−中にセ
ッ゛トし、室温において、1.5容量%のオゾンを含む
空気を流し、2時間処理した。処理後、水でよく洗い、
45mmφのガラスシャーレにセットし、高圧蒸気滅菌
後、無菌のフィブロネクチン(シグマ社製、牛血清より
採取)のリン酸緩衝溶液(濃度0.1m+;+/if)
を塗布し、室温で乾燥させた。これらの操作は全て無菌
的に行なった。このシャーレでヒト由来子宮頚部癌細胞
(Hela 5−3)を培養した。培養液は、10%
牛脂児血清を含むイーグルMEM培地で、培養液111
当たり2×104個の培養細胞を播種し、5%炭酸ガス
、95%空気雰囲気の温度37℃の環境下、3日間の培
養を行なったところ、培養液111当たり平均3゜4×
105個の細胞数となり、良好な増殖が観察された。Example 1 and Comparative Examples Polysulfone (manufactured by UCC, Udel P17
00) with a thickness of 50μ and a diameter of 45m + nφ was set in a desiccator equipped with a gas inlet and an outlet, and air containing 1.5% by volume of ozone was flowed through it at room temperature. Treated for 2 hours. After treatment, wash thoroughly with water.
Set in a 45 mmφ glass petri dish, and after high-pressure steam sterilization, add a phosphate buffer solution (concentration 0.1 m+; +/if) of sterile fibronectin (manufactured by Sigma, collected from bovine serum).
was applied and dried at room temperature. All these operations were performed aseptically. Human cervical cancer cells (Hela 5-3) were cultured in this petri dish. Culture solution is 10%
Culture medium 111 in Eagle MEM medium containing beef tallow serum.
When 2 x 104 cultured cells were seeded per cell and cultured for 3 days in an environment of 5% carbon dioxide and 95% air at a temperature of 37°C, an average of 3°4
The number of cells was 105, and good proliferation was observed.
一方、ポリスルホンフィルムをそのまま用いた他は、上
記実施例と同様に試験を行なった比較例では、培養液1
′11当たり平均1.2×105個の細胞数となりだ。On the other hand, in a comparative example in which the test was conducted in the same manner as in the above example except that the polysulfone film was used as it was, the culture solution 1
The average number of cells per '11 was 1.2 x 105.
実施例2
ポリエーテルイミド(エンジニアリングプラスチック社
製商品名、ULTEM)をN−メチルー2−ピロリドン
に溶解し、18重量%溶液を調整した。この溶液をガラ
ス板上にドクターナイフで厚さ300μmに流延し、一
定時間放置後、ガラス板ごと温度15℃に保たれたN−
メチル−2−ピロリドン5%水溶液中に浸漬し凝固させ
多孔質フィルムを得た。この膜を実施例1と同じ方法に
より1.5容量%のオゾンを含む空気で3時間処理した
。処理したフィルムを流水中に1時間置き、乾燥後、5
0 mmφの円形に打抜き、高圧蒸気滅菌した。その後
、メタルスクリーンを用いて、無菌のコラーゲン溶液(
タイプ11濃度0.3%)の処理幅40趨、非処理幅4
0μmからなる縞模様を形成した後、乾燥させて縞模様
のコラーゲンを担持した。Example 2 Polyetherimide (trade name, ULTEM, manufactured by Engineering Plastics Co., Ltd.) was dissolved in N-methyl-2-pyrrolidone to prepare a 18% by weight solution. This solution was cast onto a glass plate with a doctor knife to a thickness of 300 μm, and after being left for a certain period of time, the N-
It was immersed in a 5% aqueous solution of methyl-2-pyrrolidone and coagulated to obtain a porous film. This membrane was treated in the same manner as in Example 1 with air containing 1.5% by volume of ozone for 3 hours. The treated film was placed in running water for 1 hour, and after drying,
It was punched out into a 0 mm diameter circle and sterilized with high pressure steam. Then, using a metal screen, sterile collagen solution (
Type 11 concentration 0.3%) treated width 40, untreated width 4
After forming a striped pattern of 0 μm, it was dried to support the striped collagen.
細胞培養用基材(1)としての上記複合フィルムを、予
めエチレンオキサイドガス滅菌した図に示すポリカーボ
ネート製ハウジング(3)を有する細胞培養器(内径4
7mmφ)に、サポートスクリーン(2)と共に装着し
、孔(4)からヒト胎児包皮由来細胞(F 1 ow
7000)のイーグルMEM(10%牛脂児血清添加
)懸濁液(細胞数2X104個/獣)を満した。孔(4
)には、細菌をカットするフィルター付きの蓋(7)を
し、管(5)を通して新鮮なイーグルMEM培地を池流
し、37℃で1週間培養を行なった。培養終了後、フィ
ルムに付着している細胞数を測定したところ、5.2X
104個/11に増殖していることがわかった。The above composite film as a cell culture substrate (1) was previously sterilized with ethylene oxide gas in a cell culture vessel (with an inner diameter of 4
7 mmφ) together with the support screen (2), and human fetal foreskin-derived cells (F 1 ow
7000) was filled with Eagle MEM (10% tallow serum supplemented) suspension (2 x 104 cells/animal). Hole (4
) was covered with a lid (7) equipped with a filter to cut out bacteria, fresh Eagle MEM medium was poured into the tank through the tube (5), and cultured at 37°C for one week. After culturing, the number of cells attached to the film was measured and found to be 5.2X.
It was found that the number of cells had grown to 104/11.
〈発明の効果〉
以上のように、この発明の細胞培養用基材によれば、オ
ゾンにより表面処理された高分子基材の表面上に、糖蛋
白質等が担持されているので、糖蛋白質等を基材上に強
固に固定化することができる。さらに、糖蛋白質等は、
細胞との親和性に優れ、接着性を高めることができると
共に細、胞を伸展、増殖に適した形態、配列で接着させ
ることができるので、高密度かつ長期間の細胞培養が可
能になるという特有の効果を奏する。従って、この発明
の細胞培養用基材は、動物細胞の培養によるホルモン等
の有用物の生産システムに利用できる他、例えばインス
リン産生細胞を基材表面に接着、培養することにより人
工膵臓が形成できるように人工臓器の構築に利用できる
。<Effects of the Invention> As described above, according to the cell culture substrate of the present invention, glycoproteins, etc. are supported on the surface of the polymer substrate surface-treated with ozone. can be firmly immobilized on the substrate. Furthermore, glycoproteins etc.
It has excellent affinity with cells and can increase adhesion, as well as allow cells and cells to adhere in a form and arrangement suitable for expansion and proliferation, making it possible to culture cells at high density and over long periods of time. It has a unique effect. Therefore, the cell culture substrate of the present invention can be used in a system for producing useful products such as hormones by culturing animal cells, and can also form an artificial pancreas by, for example, attaching and culturing insulin-producing cells to the surface of the substrate. It can be used to construct artificial organs.
図は、本発明の細胞培養用基材を用いた細胞培養器の一
例を示す断面図である。
(1)・・・細胞培養用基材、
(2)・・・サポートスクリーン、(3)・・・/1ウ
ジング、(4)・・・孔、(5)・・・管。The figure is a sectional view showing an example of a cell culture device using the cell culture substrate of the present invention. (1)...Substrate for cell culture, (2)...Support screen, (3).../1 Uzing, (4)...Hole, (5)...Tube.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2900787A JPS63196277A (en) | 1987-02-10 | 1987-02-10 | Substrate for cell culture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2900787A JPS63196277A (en) | 1987-02-10 | 1987-02-10 | Substrate for cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63196277A true JPS63196277A (en) | 1988-08-15 |
Family
ID=12264348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2900787A Pending JPS63196277A (en) | 1987-02-10 | 1987-02-10 | Substrate for cell culture |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63196277A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
US5589390A (en) * | 1989-09-11 | 1996-12-31 | Nitto Denko Corporation | Vermin exterminating element and vermin exterminating method |
-
1987
- 1987-02-10 JP JP2900787A patent/JPS63196277A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162225A (en) * | 1989-03-17 | 1992-11-10 | The Dow Chemical Company | Growth of cells in hollow fibers in an agitated vessel |
US5589390A (en) * | 1989-09-11 | 1996-12-31 | Nitto Denko Corporation | Vermin exterminating element and vermin exterminating method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2244659C (en) | Biological reactor for the cultivation of cells | |
Wung et al. | Hollow fibre membrane bioreactors for tissue engineering applications | |
US5385836A (en) | Nonwoven fabric coated with a mixture of silk fibroin, gelatin and insolubilized chitosan for use as a carrier for animal cells | |
JPS63196286A (en) | Substrate for cell culture | |
Vunjak-Novakovic et al. | Cell seeding of polymer scaffolds | |
JP4187167B2 (en) | Modified cross-section hollow fiber membrane cell-containing device | |
JPS63196281A (en) | Substrate for cell culture | |
US5702949A (en) | Culture method for multilayer growth of anchorage-dependent cells | |
WO1989010397A1 (en) | Process for culturing animal cells on a large scale and process for preparing supporting substrate for that process | |
JPS63198978A (en) | Substrate for cell culture | |
JPS63196277A (en) | Substrate for cell culture | |
JPS63196273A (en) | Substrate for cell culture | |
JPH06277050A (en) | Immobilization material for animal cell and culture method | |
JPS63196280A (en) | Substrate for cell culture | |
Zhou et al. | Microspheres for cell culture | |
JP3219305B2 (en) | Carrier for immobilizing animal cells and cell culture method using the same | |
JPS63196272A (en) | Substrate for cell culture | |
JPS63198981A (en) | Substrate for cell culture | |
JPH0833474A (en) | Culture base for adhered animal cell | |
JPS63196278A (en) | Substrate for cell culture | |
JPH0833475A (en) | Culture medium for adhered animal cell | |
JPS63196285A (en) | Substrate for cell culture | |
JPS63196274A (en) | Substrate for cell culture | |
JPS63196275A (en) | Substrate for cell culture | |
JPS63196283A (en) | Substrate for cell culture |